Effects of rofecoxib, celecoxib, and parecoxib on anti-IgE-induced histamine release from human skin mast cells and basophils.
D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D001491:Basophils / Q000187:drug effects / Q000276:immunology; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007555:Isoxazoles / Q000494:pharmacology*; D007783:Lactones / Q000494:pharmacology*; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology; D011720:Pyrazoles; D012867:Skin / Q000166:cytology; D013449:Sulfonamides / Q000494:pharmacology*; D013450:Sulfones
D000888:Antibodies, Anti-Idiotypic; D016861:Cyclooxygenase Inhibitors; D007555:Isoxazoles; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C026408:anti-IgE antibodies; C116926:rofecoxib; C409945:parecoxib; D000068579:Celecoxib